Millions of Americans take fish oil supplements in hopes of protecting their memory and keeping their brains healthy as they age. These products have become a major business, with Americans spending more than $1 billion each year on supplements containing omega-3 fatty acids. These essential nutrients help build and maintain the connections between brain cells that support memory, learning, and other cognitive functions.
But a new study suggests that getting more omega-3s into the brain through supplements may not provide the protection many people expect. Researchers at Keck Medicine of USC found that even when high doses of omega-3s successfully reached the brain, they did not produce measurable improvements in memory, thinking abilities, or protection against brain shrinkage. The findings, published in eBioMedicine, come from a two-year clinical trial involving older adults considered to be at increased risk of developing Alzheimer's disease.
Despite taking omega-3 supplements daily, participants showed no significant cognitive advantage over those who received a placebo. "We all wish there was a silver bullet for preventing Alzheimer's, but our findings showed that fish oil supplements do not appear to protect brain health," said Hussein Naji Yassine, MD, director of the USC Center for Personalized Brain Health and lead investigator of the study. "While omega-3s play an important role in forming brain cell connections needed for cognition, our results do not support fish oil supplements as a preventive measure against Alzheimer's." A Two-Year Study Tests Fish Oil's Brain Benefits To investigate whether omega-3 supplements could protect the aging brain, researchers enrolled 365 adults between the ages of 55 and 80.
All participants rarely ate fish, a major dietary source of omega-3 fatty acids, and were considered at elevated risk for Alzheimer's disease. Nearly half (47%) carried APOE4, a gene variant associated with a substantially higher risk of developing Alzheimer's later in life. Although having this variant does not mean someone will necessarily develop the disease, it is the strongest known genetic risk factor for late-onset Alzheimer's.
Participants were randomly assigned to receive either a daily fish oil supplement or a placebo, an inactive treatment used for comparison. The supplements provided 2,000 mg of docosahexaenoic acid (DHA), an omega-3 fatty acid that is especially important for the brain. DHA is a major component of brain cell membranes, helping maintain the structure and function of neurons.
It also supports communication between nerve cells, making it an important nutrient for normal brain activity. The study was double-blind, meaning neither participants nor researchers knew who was receiving the active supplement during the trial. This approach helps reduce bias and makes it easier to determine whether any observed benefits are actually caused by the treatment.
Extract — continue reading at the source.
